Document is current
Any future updates will be listed below
-
Authors
Vasilevskaya, Anna
Taghdiri, Foad
Multani, Namita
Ozzoude, Miracle
Tarazi, Apameh
Khodadadi, Mozhgan
Wennberg, Richard
Rusjan, Pablo
Houle, Sylvain
Green, Robin
Colella, Brenda
Blennow, Kaj
Zetterberg, Henrik
Karikari, Thomas
Mikulis, David
Hazrati, Lili-Naz
Kovacs, Gabor G.
Davis, Karen Deborah
Tator, Charles
Tartaglia, Maria Carmela https://orcid.org/0000-0002-5944-8497
- License Information
-
More Information
Article History
Received: 5 February 2022
Revised: 26 May 2022
Accepted: 9 June 2022
First Online: 25 June 2022
Declarations
:
: HZ has served at scientific advisory boards for Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies, and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. GGK has served at advisory board for Biogen.
: This study was approved by the Research Ethics Board of the University Health Network and written informed consent was obtained from all participants.
: Not applicable.
